HLA Allele Controls n=524 LTI n= 218 PTB n=318 Controls vs LTI LTI vs PTB
HLA-A* n (%) n (%) n (%) Pa OR 95%CI P OR 95%CI
1 56 (10.69) 20 (9.17) 28 (8.81)            
2 132 (25.19) 76 (34.86) 82 (25.79) 0.0098 0.63 0.45-0.89 0.0302 0.65 0.45-0.94
3 69 (13.17) 16 (7.34) 38 (11.95)            
11 43 (8.21) 8 (3.67) 26 (8.18)            
23 19 (3.62) 5 (2.29) 7 (2.20)            
24 40 (7.63) 15 (6.88) 35 (11.01)            
25 12 (2.29) 6 (2.75) 11 (3.46)            
26 16 (3.05) 9 (4.13) 8 (2.52)            
29 48 (9.16) 22 10.09) 30 (9.43)            
30 20 (3.82) 9 (4.13) 10 (3.14)            
31 13 (2.48) 4 (1.83) 9 (2.83)            
32 12 (2.29) 9 (4.13) 8 (2.52)            
33 16 (3.05) 8 (3.67) 14 (4.40)            
34 1 (0.19) 0 (0.0) 2 (0.63)            
66 4 (0.76) 0 (0.0) 0 (0.0)            
68 22 (4.20) 9 (4.13) 10 (3.14)            
74 0 (0.0) 1 (0.46) 0 (0.0)            
80 1 (0.19) 1 (0.46) 0 (0.0)            
aUncorrected p value. After Bonferroni correction for multiple comparisons p values were not significant. The sum of the absolute numbers of the two alleles is twice the number of patients and controls. One PTB patient could not be HLA typed and for this reason in all the tables n is 318 instead 320.
Table 2: Distribution of HLA-A* allele frequencies in controls, individuals with LTI and PTB patients.